Screener
Jade Biosciences JBIO Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from stock option exercises | 45 | — |
| Net cash used in financing activities | (795) | (700) |
| Effect on exchange rates on cash and cash equivalents | (7) | — |
| Net decrease in cash and cash equivalents | (33,353) | (19,457) |
| Cash and cash equivalents at beginning of period | 88,438 | 69,386 |
| Cash and cash equivalents at end of period | $55,085 | $49,929 |
| Supplemental disclosure of non-cash operating, investing, and financing activities: | ||
| Purchases of property and equipment in accounts payable | — | $5 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's net change in cash?
- Jade Biosciences (JBIO) reported net change in cash of -$33.35M in Q1 2026.
- How has Jade Biosciences's net change in cash changed year-over-year?
- Jade Biosciences's net change in cash decreased by 71.4% year-over-year, from -$19.46M to -$33.35M.
- What is the long-term trend for Jade Biosciences's net change in cash?
- Over 2 years (2022 to 2025), Jade Biosciences's net change in cash has grown at a -22.6% compound annual growth rate (CAGR), from -$31.8M to $19.05M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Jade Biosciences's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude